benzoxazoles has been researched along with Psoriasis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alani, R; Ali, D; Ardianto, C; Ayoub, R; Goh, KW; Jarrar, Q; Jilani, J; Moshawih, S | 1 |
| Furue, M; Tsuji, G; Yumine, A | 1 |
| Schöldgen, W | 1 |
| Tronnier, H | 1 |
4 other study(ies) available for benzoxazoles and Psoriasis
| Article | Year |
|---|---|
Synthesis and In-Vivo Evaluation of Benzoxazole Derivatives as Promising Anti-Psoriatic Drugs for Clinical Use.
Topics: Animals; Benzoxazoles; Disease Models, Animal; Imiquimod; Mice; Mice, Inbred CBA; Pharmaceutical Preparations; Psoriasis; Skin | 2022 |
Selective PPARα agonist pemafibrate inhibits TNF-α-induced S100A7 upregulation in keratinocytes.
Topics: Benzoxazoles; Butyrates; Cell Line; Drug Evaluation, Preclinical; Humans; Keratinocytes; PPAR alpha; Psoriasis; S100 Calcium Binding Protein A7; Signal Transduction; Tumor Necrosis Factor-alpha; Up-Regulation | 2020 |
[Ambulatory treatment of psoriasis with psoil].
Topics: Administration, Topical; Anti-Inflammatory Agents; Benzoxazoles; Dermatologic Agents; Humans; Hydrocortisone; Psoriasis | 1967 |
[Indications for the treatment of psoriasis vulgaris in practice].
Topics: Benzoxazoles; Dermatologic Agents; Humans; Psoriasis | 1966 |